Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1235 |
|
| Actual shortage: | 57 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1142 (92%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
7 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-08-11 | 2018-01-26 | 18893 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-10-27 | 2018-05-18 | 27359 |
| PMS-ROSUVASTATIN | 40MG | TABLET | Resolved | 2018-05-04 | 2018-06-07 | 48563 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2018-05-18 | 2018-06-29 | 49753 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-06-28 | 2019-07-31 | 87992 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-28 | 2019-07-31 | 87995 |
| PMS-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2017-04-07 | 2017-07-25 | 6152 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2018-02-12 | 2018-06-07 | 39555 |
| PMS-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2022-11-11 | 2023-04-06 | 174381 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Actual shortage | 2024-04-05 | 2024-04-05 | 224605 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-09-08 | 2018-04-19 | 21718 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-09-19 | 2017-10-11 | 22808 |
| PMS-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32134 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32139 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2018-01-26 | 2018-05-18 | 37334 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2019-07-31 | 2020-06-10 | 90485 |
| PMS-SERTRALINE | 50MG | CAPSULE | Avoided shortage | 2019-11-15 | 2019-11-18 | 98853 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-11-15 | 2019-11-18 | 98856 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-12-24 | 2019-12-24 | 102061 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-06-26 | 2023-08-07 | 196459 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-11-16 | 2021-11-16 | 149394 |
| PMS-CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-11-16 | 2021-11-16 | 149397 |
| PMS-CELECOXIB | 200MG | CAPSULE | Discontinued | 2022-08-18 | 2022-08-18 | 166948 |
| PMS-CELECOXIB | 200MG | CAPSULE | Discontinued | 2022-08-18 | 2022-08-18 | 166951 |
| PMS-CHLORAL HYDRATE SYRUP 100MG/ML | 100MG | SYRUP | Discontinued | 2018-08-24 | 2018-08-25 | 59103 |
| PMS-CHLORAL HYDRATE SYRUP 100MG/ML | 500MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149409 |
| PMS-CILAZAPRIL | 1.0MG | TABLET | Discontinued | 2020-04-02 | 2022-01-18 | 110517 |
| PMS-CILAZAPRIL | 1.0MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111063 |
| PMS-CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111069 |
| PMS-CILAZAPRIL | 5.0MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111072 |
| PMS-CILAZAPRIL | 5.0MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111075 |
| PMS-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2023-09-20 | 2023-09-20 | 204849 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2023-09-20 | 2023-09-20 | 204854 |
| PMS-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2023-10-13 | 2023-10-13 | 206970 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2023-10-13 | 2023-10-13 | 206973 |
| PMS-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117772 |
| PMS-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2023-05-10 | 2023-05-11 | 192157 |
| PMS-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2023-05-10 | 2023-05-11 | 192160 |
| PMS-CLOBAZAM | 10MG | TABLET | Discontinued | 2020-06-16 | 2020-06-16 | 118002 |
| PMS-CLOBETASOL | 0.05% | OINTMENT | Discontinued | 2017-04-20 | 2017-05-03 | 7540 |